期刊文献+

白细胞介素-6基因型及血清水平与急性心肌梗死的关系 被引量:3

Interleukin-6 serum level and genotypes in patients with acute myocardial infarction
原文传递
导出
摘要 目的分析急性心肌梗死患者白细胞介素-6(IL-6)基因启动子-572C/G、-634C/G的多态性,探讨IL-6的基因型及其血清水平与急性心肌梗死的关系.方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)的分析方法,检测了128例急性心肌梗死患者和145例健康对照者IL-6基因多态性,同时采用酶联免疫吸附试验检测IL-6的血清水平.结果急性心肌梗死组IL-6水平显著高于对照组(P<0.01),IL-6-572C/G基因型和等位基因频率在急性心肌梗死组和对照组比较,差异有显著性(P<0.05),与健康对照组相比,发现G等位基因携带者患急性心肌梗死的的相对风险度增加1.740倍(OR=1.740,95%CI=1.135~2.668).携带G等位基因的急性心肌梗死患者血清IL-6水平显著高于不携带者(P<0.01).IL-6基因-634C/G多态性在急性心肌梗死组和对照组之间比较差异无显著性(P>0.05).结论IL-6基因-572C/G多态性与急性心肌梗死之间存在相关关系,其中G等位基因可能是急性心肌梗死发病的遗传易感基因;携带G等位基因的个体可能通过促进IL-6的高度表达进而增加了急性心肌梗死的发病风险. Objective To analyze polymorphism of the interleukin-6 (IL-6) gene promoter-572C/G and -634C/G in patients with acute myocardial infarction (AMI), and to study the relation between serum levels and genotype of interleukin-6. Methods The polymorphism of IL-6 was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 128 AMI patients and 145 healthy persons, The serum level of IL-6 was determined by enzyme-linked immanosorbent assay (ELISA). Results. AMI group showed significantly higher serum level of IL-6 than control group ( P 〈 0.01 ). There was a significant difference in frequencies of allele and genotype in IL-6 gene-572C/G polymorphism between AMI and control groups ( P 〈 0.01 ). IL-6 allele G carriers increased onset risk with 1.740 fold for AM1 (OR = 1.740, 95% CI = 1. 135-2.668) compared with healthy persons. The distribution of IL-6 gene-634C/G polymorphism was not different between AMI group and control group (P 〉 0.05 ). Conclusion IL-6 gene-572C/G polymorphism is associated with AMI. The IL-6 allele G carriers may be at increased risk of AMI due to enhanced the IL-6 expression.
出处 《中华急诊医学杂志》 CAS CSCD 2005年第8期636-639,共4页 Chinese Journal of Emergency Medicine
基金 广西卫生厅课题(Z2004037) 广西教育厅课题(200420) 广西青年科学基金资助项目(0447060)
关键词 白细胞介素-6 基因型 血清水平 急性心肌梗死 IL-6 聚合酶链反应 Acute myocardial infarction Interleukin-6 Genotype
  • 相关文献

参考文献9

  • 1李燕屏,江慧琳,陈晓辉,林佩仪,张庆光,刘国斌,于宪,熊龙根.急性心肌梗死与再灌注后血浆肿瘤坏死因子α、白细胞介素-6的变化[J].中华急诊医学杂志,2003,12(4):233-234. 被引量:13
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis.Circulation, 2002, 105 (9): 1135-1143.
  • 3Woods A, Brull DJ, Humphries SE, et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J, 2000, 21 (19): 1574-1583.
  • 4Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med,1999, 340 (2): 115-26.
  • 5Ikeda U, Ito T, Shimada K, et al. Interleukin-6 and acute coronary syndrome. Clin Cardiol, 2001, 24 (11): 701-704.
  • 6Brull DJ, Montgomery HE, Sanders J, et al. Interleukin-6 gene-174g> c and-572g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. ArteriosclerThromb Vasc Biol, 2001, 21 (9): 1458-1463.
  • 7Kitamura A, Hasegawa G, Obayashi H, et al. Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med, 2002, 19 (12):1000-1005.
  • 8Rus H, Niculescu F. Inflammatory response in unstable angina.Circulation, 1999, 100 (19): 96-98.
  • 9Georges JL, Loukaci V, Poirier O, et al. Interleukin-6 gene polymorphism and susceptibility to myocardial infarction: the ECTIM study. J Mol Med, 2001, 79 (5-6): 300-305.

二级参考文献1

共引文献12

同被引文献28

  • 1张玉莹,林平,王旖旎,赵振娟,刘赢.急性心肌梗死患者急性应激障碍影响因素的路径分析[J].中华急危重症护理杂志,2021(1):37-43. 被引量:9
  • 2何春燕,周新,熊鹰,王玲,吴洁,喻红.急性冠脉综合征患者MMP-3基因启动子5A/6A的多态性分析[J].中华急诊医学杂志,2004,13(11):748-750. 被引量:4
  • 3魏明,卢永申.质粒编码白细胞介素-4在胶原诱导鼠关节炎中的作用研究[J].中华风湿病学杂志,2005,9(5):273-276. 被引量:4
  • 4Yan JC, Wu ZG, Kong XT, et al. Relation between upregulation of CD40-CD40 ligand system and serum levels of matrix metalloproteinases and complex stenosis morphology in patients with acute coronary syndrome[J]. Acta Pharmacol Sin, 2004, 25(2):251-256.
  • 5Yan JC, Wu ZG, Li L, et al. Clinical implication of increased expression of CD40L in patients with acute coronary syndromes[J]. Chin Med J, 2002, 115(4) :491-493.
  • 6Yan JC, Zhu J, Gao L, et al. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes[J]. Clinica Chimica Acta, 2004, 343(1/2):155-159.
  • 7Jacobson EM, Concepcion E, Oasi T, et al. A Graves' disease-associated kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology [J]. Endocrinology, 2005, 146(6): 2684-2691.
  • 8Kim TY, Park YJ, Hwang JK, et al. A C/T polymorphism in the 5'- untranslated region of the CD40 gene is associated with Graves' disease in Koreans[J]. Thyroid, 2003, 13(10) :919-925.
  • 9Michelson AD, Bamard MR, Krueger LA, et al. Evaluation of platelet function by flow cytometry[J]. Methods, 2000, 21(3):259-270.
  • 10Kroczek R, Hamelmann E. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies[J]. J Allergy Clin Immunol, 2005, 116(4):906-909.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部